Runx3はCD8+のT細胞在留を非リンパ球組織および腫瘍にプログラムする
J Justin Milner1, Clara Toma1, Bingfei Yu1
1Division of Biological Sciences, University of California, San Diego, La Jolla, California, USA.
Nature
|December 7, 2017
まとめ
転写因子Runx3は,組織内定の記憶CD8+T細胞 (TRM) の発達と持続に不可欠である. Runx3は腫瘍のT細胞在留にも影響し,がん免疫療法の結果に影響します.
科学分野:
- 免疫学
- 細胞生物学
- 分子生物学
背景:
- 組織内定の記憶CD8+T細胞 (TRM) は,病原体の侵入部位での迅速な免疫反応に不可欠である.
- TRM細胞の分化と維持を制御する分子メカニズムは,まだ完全に理解されていません.
研究 の 目的:
- TRM細胞の分化とホメオスタシスを制御する重要な分子調節体を特定する.
- TRM細胞機能におけるRunx3の役割とそのがん免疫への影響を調査する.
主な方法:
- TRM前駆細胞と循環する記憶前駆細胞における遺伝子発現とクロマチンのアクセシビリティの比較分析.
- 制御要因を特定するための計算式および体内RNA干渉スクリーニング.
- TRM細胞の分化とメラノーマの採用T細胞療法におけるマウスモデルにおけるRunx3機能の評価
主要な成果:
- TRM前駆細胞は,循環する記憶前駆細胞と比較して異なる分子プロファイルを示します.
- 転写因子Runx3は,TRM細胞の分化と組織在留の重要な調節因子として特定されています.
- Runx3欠乏は,組織におけるTRM細胞の蓄積と抗腫瘍免疫を阻害し,過剰発現はこれらのプロセスを強化する.
- Runx3活動に関連する共有されたコア遺伝子発現シグネチャーは,TRM細胞と腫瘍浸透性リンパ球で観察されています.
結論:
- Runx3は,様々な組織におけるTRM細胞群の確立と維持に不可欠な中央調節体である.
- Runx3の活動は,T細胞の腫瘍在留と関連しており,がんの免疫療法を改善する標的となる可能性を示唆している.
- Runx3の役割を理解することで,ワクチンの有効性や採用T細胞療法を強化する戦略を導き出すことができます.
関連する概念動画
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:18Lymphoid Cells and Tissues
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.